Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.
作者信息
Murray J A
出版信息
Br Med J (Clin Res Ed). 1982 Jun 5;284(6330):1710-1. doi: 10.1136/bmj.284.6330.1710-d.
Abstract
摘要
相似文献
1
Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.环磷酰胺治疗系统性红斑狼疮：膀胱癌风险超过益处。
Br Med J (Clin Res Ed). 1982 Jun 5;284(6330):1710-1. doi: 10.1136/bmj.284.6330.1710-d.
2
Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.环磷酰胺治疗系统性红斑狼疮：膀胱癌风险超过益处。
Br Med J (Clin Res Ed). 1982 Apr 17;284(6323):1160-1. doi: 10.1136/bmj.284.6323.1160.
3
Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis.接受环磷酰胺治疗系统性红斑狼疮或类风湿关节炎患者的膀胱并发症。
Ann Intern Med. 1979 Aug;91(2):221-3. doi: 10.7326/0003-4819-91-2-221.
4
Bladder cancer in a young girl with systemic lupus erythematosus treated with cyclophosphamide.一名患有系统性红斑狼疮的年轻女孩接受环磷酰胺治疗后发生膀胱癌。
Acta Urol Belg. 1991;59(1):133-7.
5
Urinary bladder complications with cyclophosphamide therapy.
Arch Intern Med. 1976 May;136(5):616-9.
6
Oral bolus cyclophosphamide--liberating libation or nauseating nostrum?
J Rheumatol. 1996 Feb;23(2):212-3.
7
Urinary bladder tumors following cyclophosphamide therapy: a report of two cases with a review of the literature.
Med Pediatr Oncol. 1985;13(2):86-91. doi: 10.1002/mpo.2950130209.
8
Bladder cancer after cyclophosphamide therapy for lupus nephritis.环磷酰胺治疗狼疮性肾炎后发生的膀胱癌。
Nephron. 1992;60(3):378-9. doi: 10.1159/000186790.
9
Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease.
Arthritis Rheum. 1973 Jul-Aug;16(4):461-7. doi: 10.1002/art.1780160405.
10
High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia.大剂量静脉注射环磷酰胺治疗系统性红斑狼疮相关再生障碍性贫血。
Arthritis Rheum. 1988 May;31(5):693-4. doi: 10.1002/art.1780310518.
本文引用的文献
1
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.2-巯基乙烷磺酸钠（美司钠）预防晚期癌症患者异环磷酰胺诱导的尿路上皮毒性
Lancet. 1980 Sep 27;2(8196):657-9. doi: 10.1016/s0140-6736(80)92703-8.
2
Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease.
Arthritis Rheum. 1973 Jul-Aug;16(4):461-7. doi: 10.1002/art.1780160405.
3
Cyclophosphamide-induced hemorrhagic cystitis in children with leukemia.
Cancer. 1975 Nov;36(5):1572-6. doi: 10.1002/1097-0142(197511)36:5<1572::aid-cncr2820360506>3.0.co;2-t.
4
Second neoplasm--a complication of cancer chemotherapy.第二原发性肿瘤——癌症化疗的一种并发症。
N Engl J Med. 1977 Jul 28;297(4):213-5. doi: 10.1056/NEJM197707282970411.
5
Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.
Adv Cancer Res. 1975;22:57-155. doi: 10.1016/s0065-230x(08)60176-1.
6
Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
Cancer. 1977 Sep;40(3):1280-96. doi: 10.1002/1097-0142(197709)40:3<1280::aid-cncr2820400343>3.0.co;2-a.
Zotero 插件